Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
10.36
-0.05 (-0.48%)
At close: May 15, 2026, 4:00 PM EDT
10.52
+0.16 (1.54%)
After-hours: May 15, 2026, 7:58 PM EDT

Alpha Tau Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
912436218---
Market Cap Growth
396.50%99.67%----
Enterprise Value
840.94375.12170.11000
Last Close Price
10.364.953.103.013.189.82
PE Ratio
--9.34-6.89-7.17-6.00-14.66
P/FCF Ratio
--13.30-9.91---
P/OCF Ratio
--16.33-11.03---
EV/EBITDA Ratio
--9.32-4.98---
EV/EBIT Ratio
--8.87-4.72---
EV/FCF Ratio
--11.45-7.72---
Debt / Equity Ratio
0.160.160.180.140.040
Debt / EBITDA Ratio
-0.34-0.34-0.37-0.39-0.17-
Debt / FCF Ratio
-0.42-0.42-0.57-0.55-0.21-
Net Debt / EBITDA Ratio
1.481.481.382.023.242.41
Net Debt / FCF Ratio
1.811.812.142.814.012.13
Quick Ratio
6.966.966.8711.5224.107.11
Current Ratio
7.457.457.4012.0724.557.41
Return on Equity (ROE)
-61.00%-61.00%-43.16%-30.67%-54.09%-84.27%
Return on Assets (ROA)
-44.21%-44.21%-37.24%-31.38%-39.61%-28.98%
Return on Invested Capital (ROIC)
-201.51%-201.51%-187.27%-226.59%-348.68%-242.42%
Return on Capital Employed (ROCE)
-48.98%-48.98%-40.54%-33.02%-41.84%-31.09%
Earnings Yield
-4.73%-10.71%-14.52%-13.95%-16.67%-6.82%
FCF Yield
-3.64%-7.52%-10.09%---
Buyback Yield / Dilution
-15.24%-15.24%-0.79%-9.20%-56.74%-0.65%
Total Shareholder Return
-15.24%-15.24%-0.79%-9.20%-56.74%-0.65%
Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q